Levels of adenosine deaminase and dipeptidyl peptidase IV in patients with panic disorder

被引:0
|
作者
Yarpuz, Asli Yolac [1 ]
Yilmaz, Ayseguel [1 ]
Soykan, Atilla [1 ]
Elguen, Serenay [2 ]
Kumbasar, Hakan [1 ]
机构
[1] Ankara U Tip Fak, Psikiyatri AD, Ankara, Turkey
[2] Ankara U Biyokimya AD, Ankara, Turkey
关键词
panic disorder; adenosine deaminase; dipeptidyl peptidase IV; immune system;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Adenosine deaminase and dipeptidyl peptidase IV are enzymes connected to T cells that play an important role in immune system functioning. In this study, in order to understand the immune processes in panic disorder, we determined the serum levels of adenosine deaminase and dipeptidyl peptidase IV in medication-free panic disorder patients and compared them to those of healthy controls. Method. Enzymes levels were determined in blood samples of 24 healthy controls and 33 panic disorder patients diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders-IV that were medication free during the previous month and medically healthy. Results: Levels of both enzymes were significantly higher in panic disorder patients than in the controls (P < 0.001 for adenosine deaminase and P < 0.05 for dipeptidyl peptidase IV). The levels of the enzymes did not correlate with sociodemographic variables, duration of the disorder presence of agoraphobia, presence of stressors, number of panic attack symptoms, and Hamilton depression and anxiety rating scale scores. In addition, the 2 enzymes' levels did not correlate with each other. There was a correlation between Hamilton anxiety rating scale score and the number of panic attack symptoms (P < 0.001); however Hamilton anxiety rating scale scores were not correlated with the other variables. Conclusion; Our results suggest that there may be a primary or secondary impaired immune state in the course of panic disorder as there is in many other psychiatric disorders, such as major depression. Future studies with larger samples are needed to clarify the relationship between the immune system and panic disorder.
引用
收藏
页码:149 / 156
页数:8
相关论文
共 50 条
  • [41] Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet’s disease
    Mustafa Calis
    Filiz Ates
    Cevat Yazici
    Kader Kose
    Mehmet Kirnap
    Meltem Demir
    Murat Borlu
    Cem Evereklioglu
    Rheumatology International, 2005, 25 : 452 - 456
  • [42] Soluble dipeptidyl peptidase IV (CD-26) in serum of patients with colorectal carcinoma
    De La Haba-Rodríguez, J
    Macho, A
    Calzado, MA
    Blázquez, MV
    Gómez, MA
    Munoz, EE
    Aranda, E
    NEOPLASMA, 2002, 49 (05) : 307 - 311
  • [43] The Course of Serum Adenosine Deaminase Levels in Patients with Pulmonary Tuberculosis
    Kartaloglu, Zafer
    Okutan, Oguzhan
    Bozkanat, Erkan
    Ugan, Mustafa Harun
    Ilvan, Ahmet
    TURKISH THORACIC JOURNAL, 2005, 6 (02) : 127 - 131
  • [44] Novel aspects of cellular action of dipeptidyl peptidase IV/CD26
    Ansorge, Siegfried
    Nordhoff, Karsten
    Bank, Ute
    Heimburg, Anke
    Julius, Heiko
    Breyer, Doreen
    Thielitz, Anja
    Reinhold, Dirk
    Taeger, Michael
    BIOLOGICAL CHEMISTRY, 2011, 392 (03) : 153 - 168
  • [45] Adenosine deaminase and xanthine oxidase levels in multiple sclerosis patients
    Gokce, Seyda Figul
    Demirpence, Ozlem
    Cigdem, Burhanettin
    Bolayir, Asli
    Ersan, Serpil
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2020, 11 : 147 - 150
  • [46] Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients
    Buljevic, Suncica
    Detel, Dijana
    Pucar, Lara Baticic
    Mihelic, Radovan
    Madarevic, Tomislav
    Sestan, Branko
    Varljen, Jadranka
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) : 2867 - 2874
  • [47] The course of serum adenosine deaminase levels in patients with pulmonary tuberculosis
    Kartaloglu, Zafer
    Okutan, Oguzhan
    Bozkanat, Erkan
    Ugan, M. Harun
    Ilvan, Ahmet
    MEDICAL SCIENCE MONITOR, 2006, 12 (11): : CR476 - CR480
  • [48] Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes
    Flatt, Peter R.
    Bailey, Clifford J.
    Green, Brian D.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 3648 - 3660
  • [49] The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases
    Augustyns, K
    Van der Veken, P
    Senten, K
    Haemers, A
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (08) : 971 - 998
  • [50] Potent and selective proline derived dipeptidyl peptidase IV inhibitors
    Edmondson, SD
    Mastracchio, A
    Beconi, M
    Colwell, LF
    Habulihaz, B
    He, HB
    Kumar, SJ
    Leiting, B
    Lyons, KA
    Mao, A
    Marsilio, F
    Patel, RA
    Wu, JK
    Zhu, L
    Thornberry, NA
    Weber, AE
    Parmee, ER
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (20) : 5151 - 5155